Not Yet RecruitingNot Applicable

Coronary Laser Atherectomy Registry From an International Taskforce

500 participantsStarted 2026-04-30

Plain-language summary

This study is a prospective, investigator-initiated, multi-center, single arm, observational registry of performance of Excimer Laser Coronary Atherectomy (ELCA) in standard use cases of percutaneous coronary intervention (PCI).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18 years or over
✓. Patient willing to be included in the registry
✓. Patients with stable coronary artery disease or acute coronary syndromes with de-novo or intra-stent restenosis (ISR) coronary lesions suitable to be treated with ELCA
✓. Mandated use of ICI:
✓. Declared PCI strategy (planned use of ELCA, need for IVL/specialty balloons/alternative atherectomy and stent strategy) prior to PCI procedure

Exclusion criteria

✕. Pregnant or breast feeding
✕. Unable to give informed consent
✕. PCI performed without IVCI attempt
✕. No ELCA use
✕. Allergy to clopidogrel, prasugrel or ticagrelor or non-compliance
✕. Post- cardiac arrest or haemodynamic instability
✕. Participation in another trial.

What they're measuring

Procedural success during index PCI

Timeframe: During Procedure

Freedom from in hospital Major Adverse Cardiovascular Events

Timeframe: Periprocedural

Trial details

NCT IDNCT07348341

SponsorCeric Sàrl

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2028-07-30

Contact for this trial

Julie FAURE

+33 (0)675574485 jfaure@cerc-europe.org

View on ClinicalTrials.gov More Stable Coronary Artery Disease trials